[The suppression of experimental allergic encephalomyelitis by heterologous antilymphocyte serum and antimetabolites].
D062365:Aminobenzoates / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy*; D005260:Female; D006168:Guinea Pigs; D008297:Male
D062365:Aminobenzoates; D000614:Aminocaproates; D000961:Antilymphocyte Serum; D000963:Antimetabolites; D003520:Cyclophosphamide
Zur Unterdrückung der experimentellen allergischen Enzephalomyelitis durch heterologes Antilymphozytenserum und Antimetabolite.